Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.
Join Ellis Martin for a compelling interview with Dr. Seth Lederman. He's an MD and the CEO of TONIX Pharmaceuticals Holding Corp. (NASDAQ:TNXP).
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.
Apiam Animal Health Ltd (ASX:AHX) speaks with ABN Newswire on the recently released financial results, as well as the company's expansion into regional areas with around 20 acquisitions over the last two years.
VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd
